• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    36.67 Down 0.61(1.64%) Feb 5, 4:00PM EST
    |After Hours : 36.67 0.00 (0.00%) Feb 5, 4:57PM EST
    Prev Close:37.28
    Open:37.22
    Bid:29.60 x 100
    Ask:43.00 x 100
    1y Target Est:47.67
    Beta:1.57462
    Next Earnings Date:11-Feb-16ACOR Earnings announcement
    Day's Range:36.42 - 37.64
    52wk Range:25.50 - 43.63
    Volume:491,778
    Avg Vol (3m):609,826
    Market Cap:1.58B
    P/E (ttm):705.19
    EPS (ttm):0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 1.64%1.58B
    BIIBDown 3.44%57.70B

    Key Statistics

    Forward P/E (1 yr):35.95
    P/S (ttm):3.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.00
    Quarterly EPS Est (Dec-15) :0.22
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback